Health Canada conducted a safety review of PICATO and concluded that there may be a link between its use and an increased risk of skin cancer. In light of the unfavourable benefit-risk profile, the manufacturer is withdrawing PICATO from the Canadian market at Health Canada’s request.
RecallTracker